The present invention provides a method of treatment of an individual with an ophthalmic condition comprising the step of: administering to the individual a therapeutically effective amount of a compound capable of modulating the activity of mineralocorticoid receptors within cells or tissue located in an eye or adjacent to an eye in the individual to be treated. Preferably, said compound is an anti-oedematous steroid, more preferably a mineralocorticoid.
申请公布号
WO2005099715(A2)
申请公布日期
2005.10.27
申请号
WO2005US12103
申请日期
2005.04.08
申请人
RETMED PTY LTD.;PEYMAN, GHOLAM, ALI;SANDERS, DONALD, ROBERT
发明人
PENFOLD, PHILIP, LESLIE;PEYMAN, GHOLAM, ALI;SANDERS, DONALD, ROBERT